The company's flagship brand, Naprosyn, also crossed the Rs 100-crore sales milestone, marking another significant ...

Venetoclax tablets are indicated for the treatment of adult patients with chronic lymphocytic leukemia (CLL) or small ...

The performance reflects the benefits of the company's strategic transition from an active pharmaceutical ingredients (API) ...

OneSource Specialty Pharma has received the Establishment Inspection Report (EIR) with a 'Voluntary Action Indicated' (VAI) ...

In a major push to advance surgical imaging capabilities in India, medical technology provider Healthware has joined hands ...

The approval of the supplemental Biologics License Application (sBLA) expands ILUMYA’s use beyond moderate-to-severe plaque ...

Through advanced materials science and early-stage collaboration with healthcare innovators, Syensqo is positioning itself as ...

Alivus Life Sciences, formerly Glenmark Life Sciences Limited, delivered a strong financial performance in the second quarter ...

The certification elevates the site’s global regulatory status, opening doors to European and other highly regulated markets ...

Senores Pharmaceuticals Limited has reported its highest-ever quarterly revenue and EBITDA for the second quarter of FY27, with revenue climbing 24.9% year-on-year to Rs 192.3 crore, against Rs 153.9 ...

In a significant shift in its business mix, the company's Ex-US markets generated Rs 6,963 million in revenue, registering a ...

Sanofi Consumer Healthcare India Limited reported a 12% year-on-year increase in revenue to Rs 263.1 crore for the third ...